A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury
暂无分享,去创建一个
G. Verleden | S. Verleden | D. Schols | I. Katz | S. Claes | E. Verbeken | B. Vanaudenaerde | A. Neyrinck | R. Vos | Géraldine Farjot | S. Ordies | Matthieu Chalopin | A. Martens | D. Van raemdonck | An Martens
[1] Filip Rega,et al. Machine perfusion of thoracic organs. , 2018, Journal of thoracic disease.
[2] G. Verleden,et al. Steroids can reduce warm ischemic reperfusion injury in a porcine donation after circulatory death model with ex vivo lung perfusion evaluation , 2016, Transplant international : official journal of the European Society for Organ Transplantation.
[3] R. Rossaint,et al. Beneficial Properties of Argon After Experimental Subarachnoid Hemorrhage: Early Treatment Reduces Mortality and Influences Hippocampal Protein Expression* , 2016, Critical care medicine.
[4] Hailin Zhao,et al. Argon protects against hypoxic-ischemic brain injury in neonatal rats through activation of nuclear factor (erythroid-derived 2)-like 2 , 2016, Oncotarget.
[5] J. Pype,et al. Argon and xenon ventilation during prolonged ex vivo lung perfusion. , 2016, The Journal of surgical research.
[6] X. Golay,et al. Inhaled 45–50% argon augments hypothermic brain protection in a piglet model of perinatal asphyxia , 2016, Neurobiology of Disease.
[7] R. Guieu,et al. Effectiveness of pure argon for renal transplant preservation in a preclinical pig model of heterotopic autotransplantation , 2016, Journal of Translational Medicine.
[8] U. Goebel,et al. Argon: a novel therapeutic option to treat neuronal ischemia and reperfusion injuries? , 2015, Neural regeneration research.
[9] G. Verleden,et al. A decade of extended‐criteria lung donors in a single center: was it justified? , 2015, Transplant international : official journal of the European Society for Organ Transplantation.
[10] S. Keshavjee,et al. Extending the donor pool: rehabilitation of poor organs. , 2015, Thoracic surgery clinics.
[11] C. Niemann,et al. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. , 2015, The New England journal of medicine.
[12] R. Rossaint,et al. Delayed Argon Administration Provides Robust Protection Against Cardiac Arrest-Induced Neurological Damage , 2015, Neurocritical Care.
[13] R. Rossaint,et al. Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by K(ATP)-channel opening. , 2014, Resuscitation.
[14] G. Verleden,et al. The site and nature of airway obstruction after lung transplantation. , 2014, American journal of respiratory and critical care medicine.
[15] Xuejun Sun,et al. Bustling argon: biological effect , 2013, Medical gas research.
[16] O. Thom,et al. Inflammatory Signalling Associated with Brain Dead Organ Donation: From Brain Injury to Brain Stem Death and Posttransplant Ischaemia Reperfusion Injury , 2013, Journal of transplantation.
[17] A. Haverich,et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients , 2012, The Lancet.
[18] M. Vizcaychipi,et al. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats* , 2012, Critical care medicine.
[19] J. Risso,et al. Ex Vivo and In Vivo Neuroprotection Induced by Argon When Given after an Excitotoxic or Ischemic Insult , 2012, PloS one.
[20] Rolf Rossaint,et al. The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. , 2012, European journal of pharmacology.
[21] J. Pype,et al. Noble Gas (Argon and Xenon)-Saturated Cold Storage Solutions Reduce Ischemia-Reperfusion Injury in a Rat Model of Renal Transplantation , 2012, Nephron Extra.
[22] G. Verleden,et al. Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[23] R. Rossaint,et al. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats* , 2011, Critical care medicine.
[24] B. Meiser,et al. Defining an extended criteria donor lung: an empirical approach based on the Eurotransplant experience 1 , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[25] P. Pagel. Cardioprotection by noble gases. , 2010, Journal of cardiothoracic and vascular anesthesia.
[26] R. Rossaint,et al. Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury , 2009, Critical care.
[27] Kyle R. Eberlin,et al. Development of reproducible histologic injury severity scores: skeletal muscle reperfusion injury. , 2008, Surgery.
[28] P. Corris,et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[29] G. Verleden,et al. Nebulized N-acetyl cysteine protects the pulmonary graft inside the non-heart-beating donor. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[30] Stephen E Kimmel,et al. The effect of primary graft dysfunction on survival after lung transplantation. , 2005, American journal of respiratory and critical care medicine.
[31] J. Kirby,et al. Pulmonary Transplantation: the role of brain death in donor lung injury , 2003, Transplantation.
[32] S. Keshavjee,et al. Ischemia-reperfusion-induced lung injury. , 2003, American journal of respiratory and critical care medicine.
[33] S. Steen,et al. Transplantation of lungs from a non-heart-beating donor , 2001, The Lancet.
[34] T. Marx,et al. Xenon: Uptake and Costs , 2001, International anesthesiology clinics.